-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Atypical HUS: Diagnosis, Management, and Discontinuation Therapy

Program: Education Program
Session: Beyond TTP: “Atypical” TMAs for the Hematologist
Hematology Disease Topics & Pathways:
Research, Autoimmune disorders, Translational Research, Clinical Practice (Health Services and Quality), Genetic Disorders, Diseases, Immune Disorders
Saturday, December 7, 2024, 2:00 PM-3:15 PM

Anuja Java

Washington University in St. Louis, St. Louis, MO

Disclosures: Java: Alexion Astra Zeneca Rare Disease: Membership on an entity's Board of Directors or advisory committees; Novartis Pharmaceuticals: Membership on an entity's Board of Directors or advisory committees; Apellis pharmaceuticals: Other: Principal Investigator .

See more of: Beyond TTP: “Atypical” TMAs for the Hematologist
See more of: Education Program
Previous Presentation | Next Presentation >>